ECSP044994A - DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURES FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATING AGENTS - Google Patents

DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURES FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATING AGENTS

Info

Publication number
ECSP044994A
ECSP044994A EC2004004994A ECSP044994A ECSP044994A EC SP044994 A ECSP044994 A EC SP044994A EC 2004004994 A EC2004004994 A EC 2004004994A EC SP044994 A ECSP044994 A EC SP044994A EC SP044994 A ECSP044994 A EC SP044994A
Authority
EC
Ecuador
Prior art keywords
derivatives
preparation
diarilcicloalquilo
procedures
activating agents
Prior art date
Application number
EC2004004994A
Other languages
Spanish (es)
Inventor
Heiner Glombik
Wendelin Frick
Lothar Schwink
Eugen Falk
Stefanie Keil
Hans Ludwig Schaefer
Wolfgang Wendler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ECSP044994A publication Critical patent/ECSP044994A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se refiere a derivados de diarilcicloalquilo, así como a sus sales fisiológicamente compatibles y derivados funcionales fisiológicamente. Se describen compuestos de fórmula (I), en donde los radicales tienen los significados indicados, así como sus sales fisiológicamente compatibles y un procedimiento para su preparación. Los compuestos tienen propiedades de disminución del nivel de lípidos y/o triglicéridos y se adecuan, por ejemplo, para el tratamiento de alteraciones del metabolismo de los lípidos, de la diabetes del tipo II y del síndrome X.The invention relates to diarylcycloalkyl derivatives, as well as their physiologically compatible salts and physiologically functional derivatives. Compounds of formula (I) are described, wherein the radicals have the indicated meanings, as well as their physiologically compatible salts and a process for their preparation. The compounds have decreasing properties of the level of lipids and / or triglycerides and are suitable, for example, for the treatment of alterations of lipid metabolism, type II diabetes and syndrome X.

EC2004004994A 2001-08-31 2004-02-27 DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURES FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATING AGENTS ECSP044994A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10142734A DE10142734A1 (en) 2001-08-31 2001-08-31 New (((oxazolylalkyl)-cycloalkyl)-alkyl)-benzoic acid derivatives, are peroxisome proliferator activated receptor agonists or antagonists used e.g. for treating lipid metabolism disorders, type II diabetes, syndrome X and obesity

Publications (1)

Publication Number Publication Date
ECSP044994A true ECSP044994A (en) 2004-04-28

Family

ID=7697283

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004004994A ECSP044994A (en) 2001-08-31 2004-02-27 DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURES FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATING AGENTS

Country Status (3)

Country Link
DE (1) DE10142734A1 (en)
EC (1) ECSP044994A (en)
ZA (1) ZA200401073B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078404B2 (en) 2002-04-11 2006-07-18 Sanofi-Aventis Deutschland Gmbh Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
US7223796B2 (en) 2002-04-11 2007-05-29 Sanofi-Aventis Deutschland Gmbh Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
US7262220B2 (en) 2002-07-11 2007-08-28 Sanofi-Aventis Deutschland Gmbh Urea- and urethane-substituted acylureas, process for their preparation and their use
AU2003249937A1 (en) 2002-07-12 2004-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
US20040157922A1 (en) 2002-10-04 2004-08-12 Aventis Pharma Deutschland Gmbh Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments
DE10306250A1 (en) 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituted N-aryl heterocycles, processes for their preparation and their use as pharmaceuticals
DE10308353A1 (en) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as medicines
US7008957B2 (en) 2003-07-25 2006-03-07 Sanofi-Aventis Deutschland Gmbh Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
US7094800B2 (en) 2003-07-25 2006-08-22 Sanofi-Aventis Deutschland Gmbh Cyanopyrrolidides, process for their preparation and their use as medicaments
BRPI0414536A (en) * 2003-09-17 2006-11-07 Novartis Ag organic compounds
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
US7498341B2 (en) 2004-01-31 2009-03-03 Sanofi Aventis Deutschland Gmbh Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
DE102004026532A1 (en) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituted Oxazole Benzoisothiazoldioxidderivate, process for their preparation and their use
JP2010500300A (en) 2006-08-08 2010-01-07 サノフィ−アベンティス Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for their preparation, agents containing these compounds, and uses thereof
DE102007005045B4 (en) 2007-01-26 2008-12-18 Sanofi-Aventis Phenothiazine derivatives, process for their preparation and their use as medicines
US8846666B2 (en) 2011-03-08 2014-09-30 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683703B1 (en) 2011-03-08 2015-05-27 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683698B1 (en) 2011-03-08 2017-10-04 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof

Also Published As

Publication number Publication date
ZA200401073B (en) 2004-08-26
DE10142734A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
UY28732A1 (en) ACID DERIVATIVES 7-PHENYLAMINE-4-QUINOLONA-3-CARBOXILICO, PROCESSES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
PY0219683A (en) AMINO-ALKYL SUBSTITUTED AROMATIC BICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
UY28123A1 (en) NEW DERIVATIVES OF AROMATIC FLUOROGLYCHIDS, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USES.
CR7261A (en) DERIVATIVES OF DIARILCICLOALQUILO, PROCEDURE FOR ITS PREPARATION AND ITS USE AS PPAR ACTIVATING AGENTS
PA8577001A1 (en) HETEROCICLICALLY SUBSTITUTED BENZOILUREAS, PROCEDURE FOR PREPARATION AND USE AS PHARMACOS
PA8607201A1 (en) SUBSTITUTED DERIVATIVES OF TIAZOL-BENZOISOTIAZOL DIOXIDE, PROCEDURE FOR PREPARATION AND USE
UY28122A1 (en) NEW DERIVATIVES OF HETEROCYCLIC FLUOROGLYCOSIDS, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THEMSELVES.
ECSP067054A (en) NEW FLUOROGLYCOSIDIC DERIVATIVES OF PIRAZOLES, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THEMSELVES
UY27761A1 (en) DERIVATIVES OF ACIL-4-CARBOXIFENILUREA, PROCEDURES FOR PREPARATION AND USE.
ECSP066855A (en) BENEFIT DERIVATIVES REPLACED BY GLUCOPIRANOSIL, MEDICATIONS CONTAINING THOSE COMPOUNDS, ITS APPLICATION AND PROCEDURE FOR PREPARATION
UY31350A1 (en) (CARBOXILALQUILENFENIL) PHENYLOXAMIDS, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT
ECSP088329A (en) NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8
UY27418A1 (en) FORMULATIONS IN COMBINATION OF PROPANOL-AMINA DERIVATIVES SUBSTITUTED WITH ARILO, TOGETHER WITH OTHER ACTIVE SUBSTANCES AND THEIR USE
PA8595901A1 (en) "N-ARILHETEROCICLOS REPLACED, PROCEDURES FOR THEIR PREPARATION, AND THEIR EMPLOYMENT AS MEDICATIONS
UY29258A1 (en) HYDROXIBYPHYL CARBOXYLIC ACIDS AND DERIVATIVES, PROCEDURES TO PREPARE THEM AND USE
UY27516A1 (en) BENCIMIDAZOLS
PA8635301A1 (en) SUBSTITUTED DERIVATIVES OF OXAZOLBENZOISOTIAZOL DIOXIDE, PROCEDURE FOR PREPARATION AND USE
UY28369A1 (en) THERAPEUTIC AGENTS
UY29079A1 (en) PHENOXYACETIC ACIDS REPLACED, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
UY28209A1 (en) DERIVATIVES OF AMINO ACIDS WITH CYCLLOQUAL, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT.
UY29065A1 (en) ARILCICLOALQUIL-SUBSTITUTED ALCANOIC ACID DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND ITS USE AS PHARMACEUTICAL PRODUCTS.
PA8596701A1 (en) DERIVATIVES OF REPLACED AMINO ACIDS WITH CYCLLOQUAL, PROCEDURE FOR PREPARATION AND USE AS MEDICATIONS
ECSP066964A (en) NEW BETA-AGONISTS, PROCEDURE FOR PREPARATION AND USE AS MEDICATIONS
UY31033A1 (en) USE OF 4-CYCLOPROPILMETOXI-N- (3,5-DICLORO-1-OXIDO-PIRIDIN-4-IL) -5- (METOXI) PIRIDIN-2-CARBOXAMIDE FOR THE TREATMENT OF TRAUMATISMS OF THE SPINAL MEDULA
UY29846A1 (en) N- (1,3,4) -TIADIAZOL-2-IL-BENCENSULPHONAMIDES, PROCESSES FOR PREPARATION AND USE AS PHARMACEUTICAL PRODUCTS